PERK, IRE1: Method of Enhancing Immunotherapy Using ER Stress Pathway Inhibitors

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Haskell Adler PhD MBA CLP
Senior Licensing Manager
Haskell.Adler@Moffitt.org
(813) 745-6596

20MA005N